Logo
Homepage
Explore Our Models
My Cart
Contact
Subscribe
Models
Our Products
MouseAtlas
iPSC Cell Lines
Knockout Cell Lines
Tumor Cell Lines
Adeno-associated Virus (AAV) Standard Capsid
Featured Catalog
Humanized Mouse Models
HUGO-GT™
HUGO-Ab™
Humanized Target Gene Models
Humanized Immune System Mouse Models
Tool Mice
Cre Mouse Lines
Disease Models
Autoimmune Disease Models
Ophthalmic Disease Models
Immunodeficient Mouse Models
Metabolic Disease Models
Neurological Disease Models
Oncology & Immuno-oncology Models
Custom Model Services
Model Generation Techniques
Turboknockoutᵀᴹ Gene Targeting
Cre-ESCs Gene Editing
Targeted Gene Editing
Genetically Engineered Animals
Knockin Mice
Knockin Rats
Knockout Mice
Knockout Rats
Transgenic Mice
Transgenic Rats
Transgenic Model Generation
Virus Packaging
Adeno-associated Virus (AAV) Packaging
Adenovirus Packaging
Lentivirus Packaging
Custom Cell Line Services
Induced Pluripotent Stem Cells (iPSCs)
Knockout Cell Lines
Knockin Cell Lines
Overexpression Cell Lines
Point Mutation Cell Lines
Breeding & Supporting Services
BAC Modification
Breeding Services
Cryopreservation & Recovery
Phenotyping Services
Preclinical Solutions
Antibody Discovery Platform
HUGO-Mab™
HUGO-Light™
HUGO-Nano™
HUGO-Ab-eKO™
Therapeutic Area
Neurology
Alzheimer's Disease (AD)
Parkinson's Disease (PD)
Huntington's Disease (HD)
Blood Brain Barrier (BBB)
Neuropathic Pain
Metabolic & Cardiovascular
Obesity
Ophthalmology
Glaucoma
Age-Related Macular Degeneration (AMD)
Retinal-related diseases
Oncology
PBMC Humanized Mouse Model
Human Immune System (HIS) Mouse Model
Immunology & Inflammation
Asthma
Drug Classification
Therapeutic Antibody Drugs
Monoclonal Antibodies (mAb)
Bispecific Antibodies (BsAb)
ADC/AOC
AI-Powered AAV Discovery
Cell Immunotherapy
Gene Therapy
Oligonucleotide Therapy
Fully Human Antibody Library
Neurology Antibodies
Metabolic & Cardiovascular Antibodies
Ophthalmology Antibodies
Oncology Antibodies
Immunology & Inflammation Antibodies
Resources
News
Blogs & Insight
Promotion
Events & Webinars
Databases
AbSeek
Rare Disease Data Center
Cell iGeneEditor™ System
Citations
Resource Vault
OriCell
About Us
Animal Health & Welfare
Corporate Overview
Facility Overview
Our Team
Our Partners
Careers
Health Reports
Contact Us
Login
Enter Keywords to Search for
OUR FEATURED PRODUCTS
Animal
Innovative Solutions & Trusted Products
Genetically Engineered Animals
Cyagen provides knockout, knockin, and transgenic models with high genetic precision to support research in genetics, pharmacology, and disease modeling.
Comprehensive Research Models
Our humanized, knockout, and disease-specific mice closely mimic human conditions, empowering your preclinical studies from rare diseases to oncology.
Custom Cell Lines
Cyagen delivers custom iPSC, knockout, and knockin cell lines for genetic studies, drug screening, and therapeutic development.
Virus Packaging Solutions
We offer AAV, lentivirus, and adenovirus packaging for gene therapy, vaccine R&D, and gene editing applications.
Antibody Therapy CRO Services
Cyagen accelerates antibody drug discovery with fully human antibody mice and AI-powered screening, supporting you from discovery to validation.
Animal Quality
We uphold the highest standards in animal welfare and qualty in our AAALAC-accredited faciities, ensuring ethical research practices.
Resource Library
UPCOMING EVENT
WEBINAR
RESOURCE VAULT
BLOG & INSIGHTS
UPCOMING EVENT
Science on Tap: A Cambridge Biotech Happy Hour
Science on Tap: A Cambridge Biotech Happy Hour
Science on Tap: A Cambridge Biotech Happy Hour — pull up a stool and talk models, mice & sequencing. Cyagen and Novogene are teaming up for an evening of good beer and better science talk. Swing by Lamplighter's upstairs taproom to meet both teams, trade notes on models, mice, and sequencing, and unwind after a long day in the lab.
September 22, 2026
Schedule Meeting
Special Event MaRS Center 2026
September 17, 2026
Schedule Meeting
German Stem Cell Network Conference 2026
September 09, 2026
Schedule Meeting
Nordic Life Science Days 2026
September 08, 2026
Schedule Meeting
CNCM Conference: Neural Circuits in Health & Disease
August 17, 2026
Schedule Meeting
Barth Syndrome Foundation's Conference 2026
July 19, 2026
Schedule Meeting
WEBINAR
RESOURCE VAULT
BLOG & INSIGHTS
Your Partners in Preclinical Progress
Pioneering life science advancements to deliver real-world health solutions.
Our Solutions: Integrated preclinical services, including:
  • ● Cell & animal model development and viral packaging.
  • ● Expert-led preclinical studies.
Your Outcome: Seamlessly translating innovative research into actionable results and successful IND applications.
Model Library
Model Library
Resources
Resources
Animal Quality
Animal Quality
Get Support
Get Support
Address:
2255 Martin Avenue, Suite E Santa Clara, CA 95050-2709, US
Tel:
800-921-8930 (8-6pm PST)
+1408-963-0306 (lnt’l)
Fax:
408-969-0336
Email:
inquiry@cyagen.com
Services
HUGO-GT™HUGO-Ab™iPSC Cell LinesAdeno-associated Virus (AAV) Standard Capsid
Drug R&D
NeurologyMetabolicOphthalmologyOncology
About Us
Animal Health & WelfareCorporate OverviewOur TeamHealth Reports
Social Media
Disclaimer: Pricing and availability of our products and services vary by region. Listed prices are applicable to the specific countries. Please contact us for more information.
Copyright © 2026 Cyagen. All rights reserved.
Privacy Policy
Site Map
Global Antibody Drug Industry Development BlueBook (Frost & Sullivan)
Key Insights
The industry is undergoing a rapid transformation driven by next-generation modalities, globalized markets, and upstream technological innovations.
  • Market Structural Shift: Monoclonal antibodies drive steady growth, but ADCs and bispecifics are rapidly accelerating, reshaping the market with higher-value innovations.
  • Chinese Market Globalization: China is actively expanding globally, evidenced by a surge in high-value cross-border license-out deals.
  • Technology-Driven Efficiency: Advanced discovery engines—exemplified by Cyagen's HUGO-Ab platform and AI algorithms—are streamlining candidate screening, optimizing molecular design, and localizing the upstream supply chain.
  • Oncology-Focused Innovation: R&D pipelines remain heavily concentrated on high-incidence malignancies like non-small cell lung cancer, utilizing complex modalities to combat clinical resistance.
Now Available for Download
Stay Updated with the Latest from Cyagen
Get the latest news on our research models, CRO services, scientific resources, and special offers—tailored to your research needs and delivered straight to your inbox.
Full Name
Email
Organization
Country
Areas of Interest
Main Area of Research